Share on StockTwits

Imperva Inc (NASDAQ:IMPV) updated its FY14 earnings guidance on Thursday. The company provided EPS guidance of ($1.25)-($0.94) for the period, compared to the Thomson Reuters consensus EPS estimate of ($1.04), Stock Ratings Network.com reports. The company issued revenue guidance of $150-160 million, compared to the consensus revenue estimate of $159.17 million.Imperva also updated its Q2 guidance to ($0.47)-($0.37) EPS.

Shares of Imperva Inc (NASDAQ:IMPV) traded up 1.92% during mid-day trading on Thursday, hitting $23.32. 1,381,245 shares of the company’s stock traded hands. Imperva Inc has a 52 week low of $22.46 and a 52 week high of $67.12. The stock has a 50-day moving average of $44.64 and a 200-day moving average of $47.94. The company’s market cap is $608.4 million.

Imperva (NASDAQ:IMPV) last released its earnings data on Thursday, May 1st. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.05. The company had revenue of $31.50 million for the quarter, compared to the consensus estimate of $31.73 million. During the same quarter in the previous year, the company posted ($0.13) earnings per share. The company’s revenue for the quarter was up 10.1% on a year-over-year basis. On average, analysts predict that Imperva Inc will post $-1.06 earnings per share for the current fiscal year.

A number of analysts have recently weighed in on IMPV shares. Analysts at Wedbush initiated coverage on shares of Imperva in a research note on Wednesday, April 16th. They set a neutral rating on the stock. On a related note, analysts at Sterne Agee upgraded shares of Imperva from a neutral rating to a buy rating in a research note on Friday, April 11th. They now have a $35.00 price target on the stock. Finally, analysts at Sterne Agee upgraded shares of Imperva from a neutral rating to a buy rating in a research note on Friday, April 11th. They now have a $35.00 price target on the stock. One analyst has rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the stock. The stock currently has an average rating of Hold and a consensus price target of $47.75.

Imperva, Inc (NASDAQ:IMPV) is engaged in providing data security solutions focused on providing visibility and control over business data across systems within the data center.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.